PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 1, 2026Medicine0 citationsOpen Access

A case report of combined oxidative phosphorylation deficiency 35 (COXPD35) in Palestine caused by novel compound heterozygous TRIT1 variants

View Full Paper
ADAli A. A. DoudinAl-Quds UniversityWOWeam N.I. OmranPalestine Polytechnic UniversitySASaja AlkomiPalestine Polytechnic University

Key Points

  • To report the first identified case of COXPD35 in Palestine caused by novel TRIT1 variants.
  • Detailed clinical assessment of a 2-year-and-6-month-old female patient.
  • Genetic diagnosis performed using whole-exome sequencing followed by Sanger sequencing.
  • Patient received various emergency interventions including IV medications for seizures and pneumonia.
  • Patient showed improvement with cessation of seizures and recovery from pneumonia.
  • Diagnosis of COXPD35 was confirmed through genetic testing, identifying novel TRIT1 variants.
  • The case emphasizes the expanding phenotypic spectrum of COXPD35.

Abstract

Rationale: Combined oxidative phosphorylation deficiency 35 (COXPD35) is an extremely rare mitochondrial disorder inherited in an autosomal recessive pattern. It results from pathogenic variants in the TRIT1 gene, leading to hypomodified cytosolic and mitochondrial tRNAs. We report the first identified case of COXPD35 in Palestine, resulting from 2 novel variants of the TRIT1 gene. Patient concerns: A 2-year-and-6-month-old female patient with seizures, neurodevelopmental delay, microcephaly, dysmorphic facial features, abnormal electroencephalogram (EEG), and thinning of the corpus callosum on Brain magnetic resonance imaging, presenting to the Emergency Department with status epilepticus, and right lower lobe pneumonia. Diagnoses: Combined oxidative phosphorylation deficiency 35 (COXPD35) caused by 2 novel TRIT1 variants that have never been previously reported in the literature, diagnosed clinically, and were identified by Whole-exome sequencing (WES) and confirmed by Sanger sequencing. Interventions: The patient received 1 shot of IV diazepam 0.3 mg/kg after IV cannulation, followed by IV ceftriaxone 500 mg twice daily, IV hydrocortisone 20 mg every 4 hours, and albuterol, ipratropium bromide, and hypertonic saline nebulizers regularly. Additionally, she was given intravenous fluids at a rate of 60 mL/h of 5% dextrose saline. She was given a 200 mg dose of phenytoin IV for seizure control. Upon clinical suspicion of a mitochondrial disease, WES was performed, followed by Sanger sequencing for confirmation of the findings. Outcomes: The patient clinically improved, with cessation of seizures, recovery from pneumonia, and confirmed diagnosis of COXPD35. Lessons: The identification of new TRIT1 variants and the expanding phenotypic spectrum of COXPD35 provides insights into its clinical and genotypic characteristics. WES and Sanger Sequencing confirm the diagnosis of COXPD35; however, it can be challenging in resource-limited settings.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Doudin et al. (2026) studied this question.

synapsesocial.com/papers/69a3d8e7ec16d51705d303d7https://doi.org/10.1097/md.0000000000047885
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1TRIT1 defect leads to a recognizable phenotype of myoclonic epilepsy, speech delay, strabismus, progressive spasticity, and normal lactate levels2022 · 19 citations
  2. 2A Case of Combined Oxidative Phosphorylation Deficiency 35 Associated with a Novel Missense Variant of the TRIT1 Gene2021 · 6 citations
  3. 3Combined defects in oxidative phosphorylation and fatty acid β-oxidation in mitochondrial disease2016 · 156 citations
  4. 4Use of a Dynamic Genetic Testing Approach for Childhood-Onset Epilepsy2019 · 66 citations
  5. 5Defective i6A37 Modification of Mitochondrial and Cytosolic tRNAs Results from Pathogenic Mutations in TRIT1 and Its Substrate tRNA2014 · 141 citations